Lymphatic invasion of the bladder wall in T1 superficial bladder carcinoma. Prognostic value
It is not usual to use as prognostic factor the bladder lymphatic vessels invasion. 519 T1 bladder tumors with complete resection and follow up of one year at least. Prophylaxis with 81 mg of BCG weekly during six weeks in 54%. Follow up without recurrence of 38 months. 49%. Tumour recurrence of 49%...
Gespeichert in:
| Veröffentlicht in: | Actas urologicas españolas 2003-04, Vol.27 (4), p.260-264 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 264 |
|---|---|
| container_issue | 4 |
| container_start_page | 260 |
| container_title | Actas urologicas españolas |
| container_volume | 27 |
| creator | Moyano Calvo, J L Ortiz Gámiz, A Poyato Galán, J M Gutiérrez González, M Sánchez Sánchez, E Alvarez-Ossorio Fernández, J L Castiñeiras Fernández, J |
| description | It is not usual to use as prognostic factor the bladder lymphatic vessels invasion.
519 T1 bladder tumors with complete resection and follow up of one year at least. Prophylaxis with 81 mg of BCG weekly during six weeks in 54%.
Follow up without recurrence of 38 months. 49%. Tumour recurrence of 49% and progression of 7%. 5.8% of the tumours are L1 and 70.7% L0. There are significative statistic relation between lympatic invasion and progression (p. 005), tumoral grade (p. 000) and actual situation (p. 02). 23% of the L1 tumours progressed vs 5% of L0. Prophylaxis with BCG reduces progression risk (33% without treatment vs 16 with BCG (p n.s.)). In multivariate analysis, resected volume (p. 024) and prophylactic treatment are independent variables for recurrence and lymphatic vessels invasion (p. 0478) and tumoral grade (p. 092) for progression.
1) L1 tumours has more probabilities of progression. 2) BCG disminishes progression rate but this is not statistical significative. 3) We need new markers to select which L1 tumours will progress. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73416408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73416408</sourcerecordid><originalsourceid>FETCH-LOGICAL-p546-8b60f6e4718a6b046bd6d578b6b2086c033c297050804d089d2b8d7c9cc0eb553</originalsourceid><addsrcrecordid>eNo9kE1LxDAYhHNQ3HX1L0hO3ipvmzRJj7L4sVDQQ49CyVfdSNrUpF3Zf2_F1dPAzMMwzBlaQ5FDRgWwFbpM6QOgoETwC7TKC0GgpGyN3upjP-7l5DR2w0EmFwYcOjztLVZeGmMj_pLeLyFucpzm0cbOaSf9f6xl1G4IvbzDrzG8DyH9lB2kn-0VOu-kT_b6pBvUPD402-esfnnabe_rbFw2ZEIx6JilPBeSKaBMGWZKvtiqAME0EKKLikMJAqgBUZlCCcN1pTVYVZZkg25_a8cYPmebprZ3SVvv5WDDnFpOaM4oiAW8OYGz6q1px-h6GY_t3x3kG7mYWpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73416408</pqid></control><display><type>article</type><title>Lymphatic invasion of the bladder wall in T1 superficial bladder carcinoma. Prognostic value</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Moyano Calvo, J L ; Ortiz Gámiz, A ; Poyato Galán, J M ; Gutiérrez González, M ; Sánchez Sánchez, E ; Alvarez-Ossorio Fernández, J L ; Castiñeiras Fernández, J</creator><creatorcontrib>Moyano Calvo, J L ; Ortiz Gámiz, A ; Poyato Galán, J M ; Gutiérrez González, M ; Sánchez Sánchez, E ; Alvarez-Ossorio Fernández, J L ; Castiñeiras Fernández, J</creatorcontrib><description>It is not usual to use as prognostic factor the bladder lymphatic vessels invasion.
519 T1 bladder tumors with complete resection and follow up of one year at least. Prophylaxis with 81 mg of BCG weekly during six weeks in 54%.
Follow up without recurrence of 38 months. 49%. Tumour recurrence of 49% and progression of 7%. 5.8% of the tumours are L1 and 70.7% L0. There are significative statistic relation between lympatic invasion and progression (p. 005), tumoral grade (p. 000) and actual situation (p. 02). 23% of the L1 tumours progressed vs 5% of L0. Prophylaxis with BCG reduces progression risk (33% without treatment vs 16 with BCG (p n.s.)). In multivariate analysis, resected volume (p. 024) and prophylactic treatment are independent variables for recurrence and lymphatic vessels invasion (p. 0478) and tumoral grade (p. 092) for progression.
1) L1 tumours has more probabilities of progression. 2) BCG disminishes progression rate but this is not statistical significative. 3) We need new markers to select which L1 tumours will progress.</description><identifier>ISSN: 0210-4806</identifier><identifier>PMID: 12830546</identifier><language>spa</language><publisher>Spain</publisher><subject>Administration, Intravesical ; Aged ; BCG Vaccine - therapeutic use ; Combined Modality Therapy ; Cystectomy ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Immunotherapy ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Neoplasms, Multiple Primary - pathology ; Prognosis ; Risk ; Urinary Bladder Neoplasms - pathology ; Urinary Bladder Neoplasms - surgery ; Urinary Bladder Neoplasms - therapy</subject><ispartof>Actas urologicas españolas, 2003-04, Vol.27 (4), p.260-264</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12830546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moyano Calvo, J L</creatorcontrib><creatorcontrib>Ortiz Gámiz, A</creatorcontrib><creatorcontrib>Poyato Galán, J M</creatorcontrib><creatorcontrib>Gutiérrez González, M</creatorcontrib><creatorcontrib>Sánchez Sánchez, E</creatorcontrib><creatorcontrib>Alvarez-Ossorio Fernández, J L</creatorcontrib><creatorcontrib>Castiñeiras Fernández, J</creatorcontrib><title>Lymphatic invasion of the bladder wall in T1 superficial bladder carcinoma. Prognostic value</title><title>Actas urologicas españolas</title><addtitle>Actas Urol Esp</addtitle><description>It is not usual to use as prognostic factor the bladder lymphatic vessels invasion.
519 T1 bladder tumors with complete resection and follow up of one year at least. Prophylaxis with 81 mg of BCG weekly during six weeks in 54%.
Follow up without recurrence of 38 months. 49%. Tumour recurrence of 49% and progression of 7%. 5.8% of the tumours are L1 and 70.7% L0. There are significative statistic relation between lympatic invasion and progression (p. 005), tumoral grade (p. 000) and actual situation (p. 02). 23% of the L1 tumours progressed vs 5% of L0. Prophylaxis with BCG reduces progression risk (33% without treatment vs 16 with BCG (p n.s.)). In multivariate analysis, resected volume (p. 024) and prophylactic treatment are independent variables for recurrence and lymphatic vessels invasion (p. 0478) and tumoral grade (p. 092) for progression.
1) L1 tumours has more probabilities of progression. 2) BCG disminishes progression rate but this is not statistical significative. 3) We need new markers to select which L1 tumours will progress.</description><subject>Administration, Intravesical</subject><subject>Aged</subject><subject>BCG Vaccine - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Cystectomy</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Recurrence, Local</subject><subject>Neoplasm Staging</subject><subject>Neoplasms, Multiple Primary - pathology</subject><subject>Prognosis</subject><subject>Risk</subject><subject>Urinary Bladder Neoplasms - pathology</subject><subject>Urinary Bladder Neoplasms - surgery</subject><subject>Urinary Bladder Neoplasms - therapy</subject><issn>0210-4806</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LxDAYhHNQ3HX1L0hO3ipvmzRJj7L4sVDQQ49CyVfdSNrUpF3Zf2_F1dPAzMMwzBlaQ5FDRgWwFbpM6QOgoETwC7TKC0GgpGyN3upjP-7l5DR2w0EmFwYcOjztLVZeGmMj_pLeLyFucpzm0cbOaSf9f6xl1G4IvbzDrzG8DyH9lB2kn-0VOu-kT_b6pBvUPD402-esfnnabe_rbFw2ZEIx6JilPBeSKaBMGWZKvtiqAME0EKKLikMJAqgBUZlCCcN1pTVYVZZkg25_a8cYPmebprZ3SVvv5WDDnFpOaM4oiAW8OYGz6q1px-h6GY_t3x3kG7mYWpA</recordid><startdate>200304</startdate><enddate>200304</enddate><creator>Moyano Calvo, J L</creator><creator>Ortiz Gámiz, A</creator><creator>Poyato Galán, J M</creator><creator>Gutiérrez González, M</creator><creator>Sánchez Sánchez, E</creator><creator>Alvarez-Ossorio Fernández, J L</creator><creator>Castiñeiras Fernández, J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200304</creationdate><title>Lymphatic invasion of the bladder wall in T1 superficial bladder carcinoma. Prognostic value</title><author>Moyano Calvo, J L ; Ortiz Gámiz, A ; Poyato Galán, J M ; Gutiérrez González, M ; Sánchez Sánchez, E ; Alvarez-Ossorio Fernández, J L ; Castiñeiras Fernández, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p546-8b60f6e4718a6b046bd6d578b6b2086c033c297050804d089d2b8d7c9cc0eb553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2003</creationdate><topic>Administration, Intravesical</topic><topic>Aged</topic><topic>BCG Vaccine - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Cystectomy</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Recurrence, Local</topic><topic>Neoplasm Staging</topic><topic>Neoplasms, Multiple Primary - pathology</topic><topic>Prognosis</topic><topic>Risk</topic><topic>Urinary Bladder Neoplasms - pathology</topic><topic>Urinary Bladder Neoplasms - surgery</topic><topic>Urinary Bladder Neoplasms - therapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Moyano Calvo, J L</creatorcontrib><creatorcontrib>Ortiz Gámiz, A</creatorcontrib><creatorcontrib>Poyato Galán, J M</creatorcontrib><creatorcontrib>Gutiérrez González, M</creatorcontrib><creatorcontrib>Sánchez Sánchez, E</creatorcontrib><creatorcontrib>Alvarez-Ossorio Fernández, J L</creatorcontrib><creatorcontrib>Castiñeiras Fernández, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Actas urologicas españolas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moyano Calvo, J L</au><au>Ortiz Gámiz, A</au><au>Poyato Galán, J M</au><au>Gutiérrez González, M</au><au>Sánchez Sánchez, E</au><au>Alvarez-Ossorio Fernández, J L</au><au>Castiñeiras Fernández, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lymphatic invasion of the bladder wall in T1 superficial bladder carcinoma. Prognostic value</atitle><jtitle>Actas urologicas españolas</jtitle><addtitle>Actas Urol Esp</addtitle><date>2003-04</date><risdate>2003</risdate><volume>27</volume><issue>4</issue><spage>260</spage><epage>264</epage><pages>260-264</pages><issn>0210-4806</issn><abstract>It is not usual to use as prognostic factor the bladder lymphatic vessels invasion.
519 T1 bladder tumors with complete resection and follow up of one year at least. Prophylaxis with 81 mg of BCG weekly during six weeks in 54%.
Follow up without recurrence of 38 months. 49%. Tumour recurrence of 49% and progression of 7%. 5.8% of the tumours are L1 and 70.7% L0. There are significative statistic relation between lympatic invasion and progression (p. 005), tumoral grade (p. 000) and actual situation (p. 02). 23% of the L1 tumours progressed vs 5% of L0. Prophylaxis with BCG reduces progression risk (33% without treatment vs 16 with BCG (p n.s.)). In multivariate analysis, resected volume (p. 024) and prophylactic treatment are independent variables for recurrence and lymphatic vessels invasion (p. 0478) and tumoral grade (p. 092) for progression.
1) L1 tumours has more probabilities of progression. 2) BCG disminishes progression rate but this is not statistical significative. 3) We need new markers to select which L1 tumours will progress.</abstract><cop>Spain</cop><pmid>12830546</pmid><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0210-4806 |
| ispartof | Actas urologicas españolas, 2003-04, Vol.27 (4), p.260-264 |
| issn | 0210-4806 |
| language | spa |
| recordid | cdi_proquest_miscellaneous_73416408 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals |
| subjects | Administration, Intravesical Aged BCG Vaccine - therapeutic use Combined Modality Therapy Cystectomy Disease Progression Female Follow-Up Studies Humans Immunotherapy Lymphatic Metastasis Male Middle Aged Neoplasm Invasiveness Neoplasm Recurrence, Local Neoplasm Staging Neoplasms, Multiple Primary - pathology Prognosis Risk Urinary Bladder Neoplasms - pathology Urinary Bladder Neoplasms - surgery Urinary Bladder Neoplasms - therapy |
| title | Lymphatic invasion of the bladder wall in T1 superficial bladder carcinoma. Prognostic value |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T14%3A29%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lymphatic%20invasion%20of%20the%20bladder%20wall%20in%20T1%20superficial%20bladder%20carcinoma.%20Prognostic%20value&rft.jtitle=Actas%20urologicas%20espa%C3%B1olas&rft.au=Moyano%20Calvo,%20J%20L&rft.date=2003-04&rft.volume=27&rft.issue=4&rft.spage=260&rft.epage=264&rft.pages=260-264&rft.issn=0210-4806&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E73416408%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73416408&rft_id=info:pmid/12830546&rfr_iscdi=true |